​

Funding Round

Series C - EpimAb Biotherapeutics

Series C - EpimAb Biotherapeutics

Investment Firm

Overview

EpimAb Biotherapeutics is a privately owned biopharmaceutical R&D company.

Announced Date

Mar 22, 2021

Closed on Date

Mar 22, 2021

Funding Type

Series C

Highlights

Location

Asia

Social

Investor Lead

N/A

Participant Investors

7

Investor Name
Participant InvestorSherpa Healthcare Partners
Participant InvestorAdrian Cheng
Participant InvestorCormorant Asset Management
Participant InvestorDecheng Capital
Participant InvestorHony Capital

Round Details and Background

EpimAb Biotherapeutics raised $120000000 on 2021-03-22 in Series C

EpimAb Biotherapeutics is a privately owned biopharmaceutical R&D company.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 05, 2019
Series B - EpimAb Biotherapeutics
3-74.0M
Mar 22, 2021
Series C - EpimAb Biotherapeutics
12-120.0M
Apr 24, 2017
Series A - EpimAb Biotherapeutics
4-25.0M

Recent Activity

There is no recent news or activity for this profile.